FORBION CAPITAL PARTNERS
Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.
FORBION CAPITAL PARTNERS
Social Links:
Industry:
Biotechnology Health Care Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
+31 35 699 30 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Google Maps
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Polaris Partners
Polaris Partners invests in healthcare and technology companies across all stages from founding to profitable growth.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-04 | F2G | Forbion Capital Partners investment in Private Equity Round - F2G | 70 M USD |
| 2022-06-29 | VectivBio | Forbion Capital Partners investment in Post-IPO Equity - VectivBio | 54 M USD |
| 2022-03-16 | Precirix | Forbion Capital Partners investment in Series B - Precirix | 80 M EUR |
| 2022-02-23 | Complement Therapeutics | Forbion Capital Partners investment in Seed Round - Complement Therapeutics | 5 M EUR |
| 2021-12-20 | ARMGO,Pharma,Inc. | Forbion Capital Partners investment in Series B - ARMGO,Pharma,Inc. | 35 M USD |
| 2021-12-17 | NorthSea Therapeutics | Forbion Capital Partners investment in Series C - NorthSea Therapeutics | 80 M USD |
| 2021-12-16 | Anaveon | Forbion Capital Partners investment in Series B - Anaveon | 110 M CHF |
| 2021-11-03 | Prilenia | Forbion Capital Partners investment in Series B - Prilenia | 43 M USD |
| 2021-10-14 | Rectify Pharmaceuticals | Forbion Capital Partners investment in Series A - Rectify Pharmaceuticals | 100 M USD |
| 2021-07-07 | NeRRe Therapeutics | Forbion Capital Partners investment in Series B - NeRRe Therapeutics | 20 M GBP |